Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants.
Biochimie
; 154: 19-24, 2018 Nov.
Article
in En
| MEDLINE
| ID: mdl-30071258
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oncogene Proteins, Fusion
/
Receptor Protein-Tyrosine Kinases
/
Carcinoma, Non-Small-Cell Lung
/
Protein Kinase Inhibitors
/
Lung Neoplasms
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Biochimie
Year:
2018
Document type:
Article